Skip to content
★ Sign in to follow
GT

Gordon Tunstall

Board Director
Director
Tabula Rasa HealthCare, Inc.Kforce IncBenefytt Technologies, Inc.
Total declarations
116
Companies
3
▲ Purchases (1 ops.)
€49k
▼ Sales (33 ops.)
€5.1M

Latest filing published 14 Jun 2022 for Tabula Rasa HealthCare, Inc..

Filing timeline

BuySale
Gordon Tunstall

Insider track record

Disclosed buys
1
Disclosed sells
33
Signal history

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Gordon Tunstall: trading record in brief

Filings by Gordon Tunstall span 3 companies, the busiest being Kforce Inc, Tabula Rasa HealthCare, Inc. and Benefytt Technologies, Inc. Between 5 May 2006 and 10 June 2022, the trades on record add up to 116 filings.

Both buying and selling appear: 1 purchase worth €49k, against 33 sales worth €5.1M. Sales outweigh purchases by €5.0M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 27 share grants and 29 option exercises. So far in 2022, the count stands at 1 purchase and no sales.

The record was last updated on 14 June 2022 with a share grant in Tabula Rasa HealthCare, Inc. The most recent open-market purchase was published on 3 March 2022, 1,712 days ago. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Gordon Tunstall

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations116 total

25 of 116 declarations